Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Huge Global Blood Cancer Market

<< Previous

Bullboard Posts

Next >>

Comment by charlierockon Apr 10, 2024 2:49pm

169 Views

Post# 35981819

RE:RE:RE:RE:RE:Huge Global Blood Cancer Market

No complexity. Nothing to see here. It's more like simplicity relativity speaking. My main concerns are; is BTD coming our way soon without anymore hurdles? How widely will our ACT be adopted? How bout a nice big joint venture or ventures. I think this is the year when we'll get some answers and maybe some surprises.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in